EGFR c.1075T>G ;(p.F359V)

Variant ID: 7-55224294-T-G

NM_005228.3(EGFR):c.1075T>G;(p.F359V)

This variant was identified in 21 publications

View GRCh38 version.




Publications:


Systematic review and meta-analysis of genomic alterations in acral melanoma.

Pigment Cell & Melanoma Research
Broit, Natasa N; Johansson, Peter A PA; Rodgers, Chloe B CB; Walpole, Sebastian T ST; Hayward, Nicholas K NK; Pritchard, Antonia L AL
Publication Date: 2022-05

Variant appearance in text: ERBB: F359V
PubMed Link: 35229492
Variant Present in the following documents:
  • PCMR-35-369-s003.xlsx, sheet 12
View BVdb publication page



Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources.

Npj Genomic Medicine
Shugg, Tyler T; Pasternak, Amy L AL; London, Bianca B; Luzum, Jasmine A JA
Publication Date: 2020

Variant appearance in text: EGFR: F359V
PubMed Link: 33145028
Variant Present in the following documents:
  • 41525_2020_156_MOESM2_ESM.xlsx, sheet 3
  • 41525_2020_156_MOESM2_ESM.xlsx, sheet 1
  • 41525_2020_156_MOESM2_ESM.xlsx, sheet 2
View BVdb publication page



The effects of combination treatments on drug resistance in chronic myeloid leukaemia: an evaluation of the tyrosine kinase inhibitors axitinib and asciminib.

Bmc Cancer
G Lindström, H Jonathan HJ; Friedman, Ran R
Publication Date: 2020-05-07

Variant appearance in text: EGFR: F359V
PubMed Link: 32380976
Variant Present in the following documents:
  • Main text
  • 12885_2020_Article_6782.pdf
View BVdb publication page



Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association
Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H
Publication Date: 2020-07

Variant appearance in text: EGFR: F359V
PubMed Link: 32107691
Variant Present in the following documents:
  • 10120_2020_1045_MOESM1_ESM.xlsx, sheet 11
View BVdb publication page



Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy.

Journal Of Hematology & Oncology
Rossari, Federico F; Minutolo, Filippo F; Orciuolo, Enrico E
Publication Date: 2018-06-20

Variant appearance in text: EGFR: F359V
PubMed Link: 29925402
Variant Present in the following documents:
  • Main text
  • 13045_2018_Article_624.pdf
View BVdb publication page



From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.

Genome Medicine
Perera-Bel, Júlia J; Hutter, Barbara B; Heining, Christoph C; Bleckmann, Annalen A; Fröhlich, Martina M; Fröhling, Stefan S; Glimm, Hanno H; Brors, Benedikt B; Beißbarth, Tim T
Publication Date: 2018-03-15

Variant appearance in text: EGFR: F359V
PubMed Link: 29544535
Variant Present in the following documents:
  • 13073_2018_529_MOESM5_ESM.pdf
View BVdb publication page



Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib.

Biologics : Targets & Therapy
Emole, Josephine J; Talabi, Taiwo T; Pinilla-Ibarz, Javier J
Publication Date: 2016

Variant appearance in text: EGFR: F359V
PubMed Link: 27013862
Variant Present in the following documents:
  • Main text
  • btt-10-023.pdf
View BVdb publication page



Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.

Cell
Creixell, Pau P; Schoof, Erwin M EM; Simpson, Craig D CD; Longden, James J; Miller, Chad J CJ; Lou, Hua Jane HJ; Perryman, Lara L; Cox, Thomas R TR; Zivanovic, Nevena N; Palmeri, Antonio A; Wesolowska-Andersen, Agata A; Helmer-Citterich, Manuela M; Ferkinghoff-Borg, Jesper J; Itamochi, Hiroaki H; Bodenmiller, Bernd B; Erler, Janine T JT; Turk, Benjamin E BE; Linding, Rune R
Publication Date: 2015-09-24

Variant appearance in text: EGFR: F359V
PubMed Link: 26388441
Variant Present in the following documents:
  • mmc4.xlsx, sheet 1
View BVdb publication page



Molecular Determinants Underlying Binding Specificities of the ABL Kinase Inhibitors: Combining Alanine Scanning of Binding Hot Spots with Network Analysis of Residue Interactions and Coevolution.

Plos One
Tse, Amanda A; Verkhivker, Gennady M GM
Publication Date: 2015

Variant appearance in text: EGFR: F359V
PubMed Link: 26075886
Variant Present in the following documents:
  • Main text
  • pone.0130203.pdf
View BVdb publication page



Second-Generation Tyrosine Kinase Inhibitors (Tki) as Salvage Therapy for Resistant or Intolerant Patients to Prior TKIs.

Mediterranean Journal Of Hematology And Infectious Diseases
Breccia, Massimo M; Alimena, Giuliana G
Publication Date: 2014-01-02

Variant appearance in text: EGFR: F359V
PubMed Link: 24455112
Variant Present in the following documents:
  • Main text
View BVdb publication page



Drug resistance missense mutations in cancer are subject to evolutionary constraints.

Plos One
Friedman, Ran R
Publication Date: 2013

Variant appearance in text: EGFR: F359V
PubMed Link: 24376513
Variant Present in the following documents:
  • Main text
  • pone.0082059.pdf
View BVdb publication page



Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.

Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Li, Tianhong T; Kung, Hsing-Jien HJ; Mack, Philip C PC; Gandara, David R DR
Publication Date: 2013-03-10

Variant appearance in text: EGFR: F359V
PubMed Link: 23401433
Variant Present in the following documents:
  • Main text
View BVdb publication page



Omics Screening for Pharmaceutical Efficacy and Safety in Clinical Practice.

Journal Of Pharmacogenomics & Pharmacoproteomics
Monte, Andrew A AA; Vasiliou, Vasilis V; Heard, Kennon J KJ
Publication Date: 2012-03-16

Variant appearance in text: EGFR: F359V
PubMed Link: 23264882
Variant Present in the following documents:
  • Main text
View BVdb publication page



The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Nature
Barretina, Jordi J; Caponigro, Giordano G; Stransky, Nicolas N; Venkatesan, Kavitha K; Margolin, Adam A AA; Kim, Sungjoon S; Wilson, Christopher J CJ; Lehár, Joseph J; Kryukov, Gregory V GV; Sonkin, Dmitriy D; Reddy, Anupama A; Liu, Manway M; Murray, Lauren L; Berger, Michael F MF; Monahan, John E JE; Morais, Paula P; Meltzer, Jodi J; Korejwa, Adam A; Jané-Valbuena, Judit J; Mapa, Felipa A FA; Thibault, Joseph J; Bric-Furlong, Eva E; Raman, Pichai P; Shipway, Aaron A; Engels, Ingo H IH; Cheng, Jill J; Yu, Guoying K GK; Yu, Jianjun J; Aspesi, Peter P; de Silva, Melanie M; Jagtap, Kalpana K; Jones, Michael D MD; Wang, Li L; Hatton, Charles C; Palescandolo, Emanuele E; Gupta, Supriya S; Mahan, Scott S; Sougnez, Carrie C; Onofrio, Robert C RC; Liefeld, Ted T; MacConaill, Laura L; Winckler, Wendy W; Reich, Michael M; Li, Nanxin N; Mesirov, Jill P JP; Gabriel, Stacey B SB; Getz, Gad G; Ardlie, Kristin K; Chan, Vivien V; Myer, Vic E VE; Weber, Barbara L BL; Porter, Jeff J; Warmuth, Markus M; Finan, Peter P; Harris, Jennifer L JL; Meyerson, Matthew M; Golub, Todd R TR; Morrissey, Michael P MP; Sellers, William R WR; Schlegel, Robert R; Garraway, Levi A LA
Publication Date: 2012-03-28

Variant appearance in text: EGFR: F359V
PubMed Link: 22460905
Variant Present in the following documents:
  • NIHMS361223-supplement-4.xlsx, sheet 3
View BVdb publication page



Oncogene Mutation Survey in MPNST Cell Lines Enhances the Dominant Role of Hyperactive Ras in NF1 Associated Pro-Survival and Malignancy.

Translational Oncogenomics
Sun, Daochun D; Tainsky, Michael A MA; Haddad, Ramsi R
Publication Date: 2012

Variant appearance in text: EGFR: F359V
PubMed Link: 22346343
Variant Present in the following documents:
  • Main text
View BVdb publication page



The energy landscape analysis of cancer mutations in protein kinases.

Plos One
Dixit, Anshuman A; Verkhivker, Gennady M GM
Publication Date: 2011

Variant appearance in text: EGFR: F359V
PubMed Link: 21998754
Variant Present in the following documents:
View BVdb publication page



The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers.

Cancer Research
Sasaki, Takaaki T; Okuda, Katsuhiro K; Zheng, Wei W; Butrynski, James J; Capelletti, Marzia M; Wang, Liping L; Gray, Nathanael S NS; Wilner, Keith K; Christensen, James G JG; Demetri, George G; Shapiro, Geoffrey I GI; Rodig, Scott J SJ; Eck, Michael J MJ; Jänne, Pasi A PA
Publication Date: 2010-12-15

Variant appearance in text: EGFR: F359V
PubMed Link: 21030459
Variant Present in the following documents:
  • Main text
View BVdb publication page



Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations.

Cancer Research
Seeliger, Markus A MA; Ranjitkar, Pratistha P; Kasap, Corynn C; Shan, Yibing Y; Shaw, David E DE; Shah, Neil P NP; Kuriyan, John J; Maly, Dustin J DJ
Publication Date: 2009-03-15

Variant appearance in text: EGFR: Phe359Val
PubMed Link: 19276351
Variant Present in the following documents:
  • Main text
View BVdb publication page



Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

Therapeutics And Clinical Risk Management
Henkes, Martin M; van der Kuip, Heiko H; Aulitzky, Walter E WE
Publication Date: 2008-02

Variant appearance in text: EGFR: Phe359Val
PubMed Link: 18728706
Variant Present in the following documents:
  • Main text
View BVdb publication page



Farnesyl transferase inhibitor resistance probed by target mutagenesis.

Blood
Raz, Tal T; Nardi, Valentina V; Azam, Mohammad M; Cortes, Jorge J; Daley, George Q GQ
Publication Date: 2007-09-15

Variant appearance in text: EGFR: F359V
PubMed Link: 17536018
Variant Present in the following documents:
  • Main text
View BVdb publication page



Treating imatinib-resistant leukemia: the next generation targeted therapies.

Thescientificworldjournal
Burgess, Michael R MR; Sawyers, Charles L CL
Publication Date: 2006-08-11

Variant appearance in text: EGFR: F359V
PubMed Link: 16906325
Variant Present in the following documents:
  • TSWJ-2006-6-390848.pdf
View BVdb publication page